Concerta (Generic Name: methylphenidate HCl ER) is an extended release delivery system central nervous system stimulant ADHD medication that is primarily used to treat attention deficit hyperactivity disorder (ADHD or ADD) in children ages 6-12, adolescents, and adults up to age 65. Concerta may improve focus for people with inattentive ADHD, and decrease impulsivity and hyperactive behavior — hallmark ADHD symptoms for many patients.
Concerta contains methylphenidate, the same active ingredient as ADHD medications such as Ritalin and Daytrana. According to the FDA, Concerta is a federally controlled substance (“Schedule II Stimulant”) because it can be abused or lead to dependence. It has not been studied by the FDA in children under the age of 6 and so use in younger children is considered “off label.” Nonetheless, it has been extensively studied in government-funded studies in children down to 3 years of age and has been shown to be both effective and safe in preschool children.
Concerta is known for its proprietary delivery system, OROS, (osmotically controlled release oral-delivery system), which allows medication to be released periodically as it travels through the body.